User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Challenges and controversies in haemophilia care in adulthood.

Primary tabs

download
  • Open access
  • PDF
  • 69.41 K
Dolan, Gerry Hermans, Cédric [UCL] Klamroth, Robert Madhok, Rajan Schutgens, Roger E G Spengler, U

Overall life expectancy and quality of life among persons with haemophilia have increased in recent years, primarily because of the advances in factor replacement therapy and better treatment of infectious diseases. Older haemophilic patients now face aging co-morbidities that are common in the general male population, such as cardiovascular or metabolic diseases, prostate hypertrophy and hepatic, prostate and other cancers. The prevalence of cardiovascular disease and incidence of vascular events among older haemophilic patients can be expected to increase and haemophilic patients may become prone to some cardiovascular risk factors, warranting preventative measures. The treatment of long-term complications of hepatitis C virus infection such as liver cirrhosis and hepatic cancer can be expected to be required in a large portion of the older haemophilia population for some years to come. Appropriate antiviral treatment and close monitoring for possible disease advancement will constitute an important part of routine medical care, and special considerations may be appropriate in conjunction with invasive procedures, chemo- or radiotherapy. At the moment, hard data on which to base the management of these conditions are largely lacking, but can be expected to increase dramatically in the coming decades. In the meantime, the ageing population of haemophilia patients should be offered the same comprehensive health care offered to the general population, which may require a restructuring of health care delivery.

Document type Article de périodique (Journal article) – Synthèse de littérature
Access type Accès libre
Publication date 2009
Language Anglais
Journal information "Haemophilia" - Vol. 15, no. Suppl 1, p. 20-27 (2009)
Peer reviewed yes
Publisher Blackwell Science ((United Kingdom) Oxford)
issn 1351-8216
e-issn 1365-2516
Publication status Publié
Affiliations UCL - MD/MINT - Département de médecine interne
UCL - (SLuc) Service d'hématologie
MESH Subject Aging ; Humans ; Male ; Neoplasms ; Risk ; Cardiovascular Diseases ; Coagulants ; Factor VIII ; HIV Infections ; HIV-1 ; Hemophilia A ; Hepacivirus ; Hepatitis C
Links
  1. Larsson, Br J Haematol, 59, 593 (1985)
  2. Ikkala, Br J Haematol, 52, 7 (1982)
  3. Jones Paul K., The Changing Prognosis of Classic Hemophilia (Factor VIII "Deficiency"), 10.7326/0003-4819-114-8-641
  4. Darby, Blood, 110, 815 (2007)
  5. Chorba, Am J Hematol, 66, 229 (2001)
  6. Plug, J Thromb Haemost, 4, 510 (2006)
  7. Triemstra Mattanja, Mortality in Patients with Hemophilia: Changes in a Dutch Population from 1986 to 1992 and 1973 to 1986, 10.7326/0003-4819-123-11-199512010-00002
  8. Rosendaal, Br J Haematol, 71, 71 (1989)
  9. Franchini, Clin Interv Aging, 2, 361 (2007)
  10. Street, Haemophilia, 12, 8 (2006)
  11. Plug, Blood, 111, 1811 (2008)
  12. Tagliaferri, Thromb Haemost, 96, 542 (2006)
  13. Manco-Johnson, N Engl J Med, 357, 535 (2007)
  14. Berntorp, Bull World Health Organ, 73, 691 (1995)
  15. http://www.ukhcdo.org/annReport.htm, United Kingdom Haemophilia Centre Doctor’s Organization. Annual Report (2007)
  16. Scholz, Hamostaseologie, 28, 150 (2008)
  17. Geraghty, Haemophilia, 12, 75 (2006)
  18. Medical and Scientific Advisory Council, Regular Administration of Clotting Factor Concentrate to Prevent Bleeding. MASAC Recommendation 170 Concerning Prophylaxis (2006)
  19. Srivastava, World Federation of Hemophilia, 1 (2005)
  20. Pipe, Haemophilia, 13, 1 (2007)
  21. Angelotta, Vox Sang, 93, 159 (2007)
  22. Arnold, Blood, 108, 460 (2006)
  23. http://www.ukhcdo.org/annReport.htm, United Kingdom Haemophilia Centre Doctor’s Organization (2006)
  24. Raffini, Br J Haematol, 136, 777 (2007)
  25. Roosendaal, Haemophilia, 12, 117 (2006)
  26. Luck James V., Silva Mauricio, Rodriguez-Merchan Carlos E., Ghalambor Navid, Zahiri Christopher A., Finn Richard S., Hemophilic Arthropathy : , 10.5435/00124635-200407000-00004
  27. Aledort, J Intern Med, 236, 391 (1994)
  28. Tuinenburg, J Thromb Haemost (2008)
  29. Koumbarelis, Thromb Haemost, 72, 808 (1994)
  30. Hofstede, Haemophilia, 14, 1035 (2008)
  31. Walsh, J Thromb Haemost, 6, 755 (2008)
  32. Rosendaal, Br J Haematol, 75, 525 (1990)
  33. Kulkarni, Am J Hematol, 79, 36 (2005)
  34. Holmberg, Lancet, 360, 1747 (2002)
  35. Friis-Moller, N Engl J Med, 349, 1993 (2003)
  36. Friis-Moller, N Engl J Med, 356, 1723 (2007)
  37. Bilora, Clin Appl Thromb Hemost, 5, 232 (1999)
  38. Sramek, Circulation, 104, 762 (2001)
  39. Bilora, Clin Appl Thromb Hemost, 7, 311 (2001)
  40. Bilora, Clin Appl Thromb Hemost, 12, 193 (2006)
  41. Sartori, Haemophilia, 14, 1055 (2008)
  42. Franchini, Thromb Haemost, 92, 1455 (2004)
  43. Girolami, Acta Haematol, 116, 120 (2006)
  44. Small, Br Heart J, 49, 604 (1983)
  45. Khallou-Laschet, Arterioscler Thromb Vasc Biol, 25, e123 (2005)
  46. Mizuno, Thromb Res, 121, 855 (2008)
  47. Gui, Thromb Res, 121, 225 (2007)
  48. Ljung, Br J Haematol, 140, 378 (2008)
  49. Kupfer, J Clin Virol, 34, 42 (2005)
  50. Darby, Lancet, 350, 1425 (1997)
  51. Jensen, Pegylated Interferon Alfa-2a (40KD) Plus Ribavirin (RBV) in Prior Non-Responders to Pegylated Interferon Alfa-2b (12KD)/RBV: Final Efficacy and Safety Outcomes of the REPEAT Study (2007)
  52. Dalgard, Hepatology, 40, 1260 (2004)
  53. Mangia, N Engl J Med, 352, 2609 (2005)
  54. Yu, Gut, 56, 553 (2007)
  55. Berg, Gastroenterology, 130, 1086 (2006)
  56. Qurishi, Lancet, 362, 1708 (2003)
  57. Franchini, J Antimicrob Chemother, 61, 1191 (2008)
  58. Yu, Hepatology, 44, 1086 (2006)
  59. Sandrin, Ultrasound Med Biol, 29, 1705 (2003)
  60. Foucher, Gut, 55, 403 (2006)
  61. Neumann, Transplantation, 82, 43 (2006)
  62. Ragni, Haemophilia, 4, 826 (1998)
  63. Wilde, AIDS, 16, 1803 (2002)
  64. Zulfikar, Haemophilia, 8, 698 (2002)
  65. Sakurai, Int J Hematol, 85, 1 (2007)
  66. Allen, Haemophilia, 13, 383 (2007)
  67. Toyoda, Br J Haematol, 112, 1071 (2001)
  68. Lambert, Thromb Haemost, 99, 963 (2008)
  69. Dawson, Haematologica, 92, e11 (2007)
  70. Larrain, Rev Med Chil, 130, 897 (2002)
  71. Bruggemann, J Cell Mol Med (2008)
Bibliographic reference Dolan, Gerry ; Hermans, Cédric ; Klamroth, Robert ; Madhok, Rajan ; Schutgens, Roger E G ; et. al. Challenges and controversies in haemophilia care in adulthood.. In: Haemophilia, Vol. 15, no. Suppl 1, p. 20-27 (2009)
Permanent URL http://hdl.handle.net/2078/125212